Alibaba Health Reports Strong 2025 Financial Results with Revenue Hike
Company

Alibaba Health Reports Strong 2025 Financial Results with Revenue Hike

CSPC Pharmaceutical's CPO301 Receives Third FDA Fast Track Designation for NSqNSCLC
CompanyDrug

CSPC Pharmaceutical’s CPO301 Receives Third FDA Fast Track Designation for NSqNSCLC

Merck Sharp & Dohme Initiates Phase III Trial of Ifinatamab Deruxtecan for Esophageal Cancer
CompanyDrug

Merck Sharp & Dohme Initiates Phase III Trial of Ifinatamab Deruxtecan for Esophageal Cancer

Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million
CompanyDeals

Terumo Corporation Acquires WuXi Biologics’ Germany Plant for EUR 150 Million

Grand Pharma's Chengdu RDC Megafactory Secures Class A Radiation Safety License
Company

Grand Pharma’s Chengdu RDC Megafactory Secures Class A Radiation Safety License

Shanghai Henlius Biotech Doses First Patient in Phase I/III Study of HLX13 for Hepatocellular Carcinoma
CompanyDrug

Shanghai Henlius Biotech Doses First Patient in Phase I/III Study of HLX13 for Hepatocellular Carcinoma

Shanghai MicroPort's Minos Stent Graft Secures Egyptian Marketing Approval
CompanyMedical Device

Shanghai MicroPort’s Minos Stent Graft Secures Egyptian Marketing Approval

Sino Biopharmaceutical's QP001 (Meloxicam) Approved by NMPA and FDA for Postoperative Pain
CompanyDrug

Sino Biopharmaceutical’s QP001 (Meloxicam) Approved by NMPA and FDA for Postoperative Pain

CompanyDeals

Porton Pharma Partners with Tong Eye on iPSC-Derived RPE Cell Therapies for Ophthalmic Diseases

InnoCare Pharma Doses First Patient in Phase II/III Trial of TYK2 Inhibitor for Vitiligo
CompanyDrug

InnoCare Pharma Doses First Patient in Phase II/III Trial of TYK2 Inhibitor for Vitiligo

Suzhou's PegBio Launches Hong Kong IPO Amid Pipeline Progress
CompanyDeals

Suzhou’s PegBio Launches Hong Kong IPO Amid Pipeline Progress

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Market Challenges
Company

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Market Challenges